3/21
08:09 pm
glue
Mixed data results for two Monte Rosa molecular glue degraders [Yahoo! Finance]
Low
Report
Mixed data results for two Monte Rosa molecular glue degraders [Yahoo! Finance]
3/21
03:17 pm
glue
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) had its price target lowered by analysts at Wells Fargo & Company from $11.00 to $10.00. They now have an "equal weight" rating on the stock.
Low
Report
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) had its price target lowered by analysts at Wells Fargo & Company from $11.00 to $10.00. They now have an "equal weight" rating on the stock.
3/20
08:14 pm
glue
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock, up previously from $15.00.
High
Report
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock, up previously from $15.00.
3/20
07:00 am
glue
Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results from MRT-6160 and MRT-2359 Programs
Low
Report
Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results from MRT-6160 and MRT-2359 Programs
3/12
02:35 pm
glue
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $19.00 price target on the stock.
Low
Report
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $19.00 price target on the stock.
3/11
07:00 am
glue
Monte Rosa Therapeutics to Present Pipeline Update and Release Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025
Low
Report
Monte Rosa Therapeutics to Present Pipeline Update and Release Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025
2/24
07:00 am
glue
Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Medium
Report
Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference